All sites C00-96,D32-33,D42-43,D45-47,D76 1472 90.6 2.4 3.2 1.1 2.8
Mouth, pharynx C00-14 21 92.4 3.8 1.9 1.9 -
  Lip C00 3 92.3 - - 7.7 -
  Tongue C02 5 95.8 - - 4.2 -
  Mouth, other C03-06 5 96.0 - 4.0 - -
  Salivary glands C07-08 4 83.3 11.1 5.6 - -
  Pharynx C01,C09-14 5 92.0 8.0 - - -
Digestive organs C15-26 252 82.9 1.4 8.2 3.2 4.3
  Oesophagus C15 8 87.5 - 7.5 2.5 2.5
  Stomach C16 24 90.8 1.7 0.8 1.7 5.0
  Small intestine C17 5 87.0 - 4.3 4.3 4.3
  Colon C18 85 94.3 - 2.4 1.9 1.4
  Rectum, rectosigmoid C19-20 46 95.7 - 1.3 2.2 0.9
  Anus C21 1 85.7 - - 14.3 -
  Liver C22 15 68.8 1.3 18.2 6.5 5.2
  Gallbladder, bile ducts C23-24 16 69.2 2.6 20.5 2.6 5.1
  Pancreas C25 47 58.5 5.1 21.6 5.1 9.7
  Other digestive organs C26 6 44.8 3.4 17.2 10.3 24.1
Respiratory organs C30-39 70 75.5 10.5 8.5 0.3 5.1
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 2 100.0 - - - -
  Lung, trachea C33-34 65 75.7 11.1 8.3 - 4.9
  Mediastinum, pleura C38 1 50.0 - 50.0 - -
Bone C40-41 2 90.9 - 9.1 - -
Melanoma of the skin C43 65 99.7 - - - 0.3
Skin, non-melanoma C44 91 99.3 0.2 0.2 - 0.2
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 9 100.0 - - - -
Breast C50 482 99.3 0.2 0.1 0.2 0.1
Female genital organs C51-58 166 96.1 1.4 0.7 0.4 1.3
  Cervix uteri C53 17 97.7 1.1 - 1.1 -
  Corpus uteri C54 88 99.8 - - - 0.2
  Uterus, other C55,C58 1 50.0 - 25.0 - 25.0
  Ovary C56 44 92.3 2.7 2.3 - 2.7
  Other female genital C51-52,C57 15 87.0 6.5 - 2.6 3.9
Urinary organs C64-68 63 88.3 1.6 4.8 1.6 3.8
  Kidney C64 37 86.6 - 6.5 2.2 4.8
  Bladder and urinary tract2 C65-68 26 90.7 3.9 2.3 0.8 2.3
Eye C69 1 71.4 14.3 - 14.3 -
Brain, central nervous system C70-72,D32-33,D42-43 53 85.3 - 9.8 1.5 3.4
Thyroid gland C73 29 95.1 4.2 - - 0.7
Other endocrine glands C74-75 2 90.0 - - - 10.0
Illdefined or unknown C76,C80 44 48.9 17.2 17.2 5.4 11.3
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 120 78.0 8.3 1.0 1.2 11.5
  Hodgkin lymphoma C81 8 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 57 98.9 - 0.4 - 0.7
  Malignant immunoproliferative diseases C88 1 83.3 - - - 16.7
  Myeloma and other plasma cell tumors C90 14 56.3 7.0 5.6 4.2 26.8
  Leukaemia C91-95 25 56.8 24.8 0.8 3.2 14.4
  Myelodysplastic syndromes D46 5 14.8 33.3 - - 51.9
  Myeloproliferaitive neoplasms D45,D47 9 56.5 10.9 - - 32.6
Not included above
  Carcinoma in situ of the breast D05 50 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 116 100.0 - - - -
  Borderline tumour of the ovary D39 17 100.0 - - - -
  Basal cell carcinoma of the skin 464 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.